SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-012571
Filing Date
2024-02-12
Accepted
2024-02-12 16:14:20
Documents
15
Period of Report
2024-02-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193300-8k425_phoenix.htm   iXBRL 8-K 61095
  Complete submission text file 0001213900-24-012571.txt   285119

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pbax-20240208.xsd EX-101.SCH 3893
3 XBRL DEFINITION FILE pbax-20240208_def.xml EX-101.DEF 26753
4 XBRL LABEL FILE pbax-20240208_lab.xml EX-101.LAB 36883
5 XBRL PRESENTATION FILE pbax-20240208_pre.xml EX-101.PRE 25377
16 EXTRACTED XBRL INSTANCE DOCUMENT ea193300-8k425_phoenix_htm.xml XML 5940
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 24620039
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)